Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy
Authors:
- Jost B JonasJJJost B Jonas
- Jochen K HaylerJHJochen K Hayler
- Antje SöfkerASAntje Söfker
- Songhomitra Panda-JonasSPSonghomitra Panda-Jonas
- 1 April 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 131 (4) , 468-471
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Letter to the EditorRetina, 1996
- INTRAVITREAL CORTICOSTEROIDS IN THE TREATMENT OF EXOGENOUS FUNGAL ENDOPHTHALMITISRetina, 1992
- Improvement in efficacy of corticosteroid therapy in an animal model of proliferative vitreoretinopathy by pretreatmentGraefe's Archive for Clinical and Experimental Ophthalmology, 1987
- Experimental and Clinical Observations of the Intraocular Toxicity of Commercial Corticosteroid PreparationsAmerican Journal of Ophthalmology, 1986
- The Clearance of Intravitreal Triamcinolone AcetonideAmerican Journal of Ophthalmology, 1982
- The Lack of Toxicity of Intravitreally Administered Triamcinolone AcetonideAmerican Journal of Ophthalmology, 1981
- Glucocorticosteroid Inhibition of Intraocular Proliferation After InjuryAmerican Journal of Ophthalmology, 1981
- Treatment of Intraocular Proliferation with Intravitreal Injection of Triamcinolone AcetonideAmerican Journal of Ophthalmology, 1980
- Inhibition of Intraocular Proliferations with Intravitreal CorticosteriodsAmerican Journal of Ophthalmology, 1980
- Intravitreal Injection of DexamethasoneArchives of Ophthalmology (1950), 1974